According to Inozyme Pharma's latest financial reports the company's current EPS (TTM) is -$2.66. In 2022 the company made an earnings per share (EPS) of -$3.24 a decrease over its 2021 EPS that were of -$3.04.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.54 | -21.76% |
2022 | -$3.24 | 6.78% |
2021 | -$3.04 | -41.04% |
2020 | -$5.15 | 130.75% |
2019 | -$2.23 |